Avita Medical | 1811094D - 股本和储备

股票价格
1.22
每天变化
0.01 0.41%
每月一次
13.02%
每年
-59.90%
Q2 预测
1.22


金融业
股票价格
AUD
资产
AUD 56.39M
现金及等价物
AUD 10.24M
销售成本
AUD 3.3M
流动资产
AUD 35.49M
流动负债
AUD 62.68M
债务
AUD 46.05M
EBIT
AUD -10.39M
EBITDA
AUD -9.69M
员工
AUD 87
EPS每股收益
AUD -0.38
股本和储备
AUD -16.65M
销售毛利
AUD 14.31M
债务利息支出
AUD 1.25M
贷款资金
AUD 42.25M
市值
AUD 159.33M
净收入
AUD -11.62M
营业费用
AUD 28.02M
营业利润
AUD -10.41M
税前利润
AUD -11.64M
销售收入
AUD 17.62M
销售和管理费用
AUD 19.03M
股票
AUD 6.93M
贸易债权人
AUD 8.96M
应收帐款人
AUD 9.11M


股本和储备 更改 日
Accuray USD 61.87M 19.3M 2025-09
Celltrion KRW 16.7T 182.36B 2025-09
Clinuvel Pharmaceuticals AUD 249.02M 8.21M 2025-12
Cochlear AUD 1.94B 12.2M 2025-12
CSL USD 18.66B 2.75B 2025-12
Cspc Pharmaceutical CNY 33.18B 71.46M 2025-12
Deva Holding AS TRY 5.79B 604.07M 2023-09
Dianthus Therapeutics USD 493.4M 53.05M 2025-12
Divis Laboratories Ltd INR 154.13B 4.44B 2025-09
Kangmei Pharma CNY 7.22B 504.3M 2025-09
Knight Therapeutics CAD 767.27M 480K 2025-12
Laboratorios Farma EUR 539.39M 22.74M 2023-12
Malin Corporation EUR 193.2M 75M 2024-12
Mayne Pharma AUD 454.19M 93.58M 2024-06
Medical Developments International AUD 54.77M 335K 2025-12
Nanosonics AUD 219.69M 9.78M 2025-12
Neuren Pharmaceuticals AUD 338.45M 15.18M 2025-12
Organigram Holdings CAD 369.46M 20.33M 2025-12
Ovoca Bio EUR 1.26M 7.41M 2025-06
Pacific Edge NZD 26.9M 811K 2025-12
Paradigm Biopharmaceuticals AUD 6M 15.18M 2025-12
Pharma Mar EUR 251.83M 54.32M 2025-12
Polynovo AUD 83.14M 121K 2025-12
PYC Therapeutics AUD 147.18M 22.82M 2025-12
Qiagen NV USD 3.78B 128.73M 2025-12
Ramsay Health Care AUD 4.79B 916.1M 2025-12
ResMed USD 6.32B 199.62M 2025-12
Sartorius EUR 2.73B 1.14B 2026-03
Sino Biopharmaceutical CNY 34B 1.48B 2025-06
Telix Pharmaceuticals AUD 416.86M 5.08M 2025-12
Tilray USD 1.58B 39.08M 2025-09
Zealand Pharma A/S 14.83B 331.99M 2025-12
Zz Pientze Pharmaceu CNY 14.47B 173.2M 2025-09